Razelle Kurzrock: SWOG has given us the opportunity to do a national immunotherapy trial for rare tumors
Razelle Kurzrock, Chair of Precision Oncology at MCW Cancer Center shared a post by SWOG Cancer Research Network on X and added:
“SWOG has given us the opportunity to do a national immunotherapy trial for rare tumors— huge unmet need.
Opened at >1,000 sites at its peak.
DART. The trial that keeps on giving.
Nivolumab and ipilimumab in rare cancers.
Kudos to Drs Sandip Patel and Young Chae who made it happen.”
Quoting SWOG Cancer Research Network’s post:
“Our SWOG Chairs’ Charles Blanke’s blog:
More Results: SWOG Trials That Keep on Giving
To keep SWOG members informed of our research results, I’m highlighting important findings presented at two recent meetings, in prostate cancer and rare sarcomatoid carcinoma lung tumors.”
View additional information.
Source: Razelle Kurzrock/X and SWOG Cancer Research Network/X
About OncoDaily
OncoDaily was founded in 2023. It is a US-based oncology media platform, which features the latest news, insights, and patient stories from the world of oncology. Within a short period of time it became one of the leading oncology media platforms globally.
OncoDaily gathers content from various sources, including social media posts from renowned oncologists from all over the world, news from oncology societies and cancer centers, patient and survivor stories, and career-related information for professionals.
The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we”.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023